Latest Articles
- The role of ISCHEMIA in stable ischemic heart disease
Decisions regarding treatment of stable ischemic heart disease must remain individualized.
- Glucocorticoid-induced osteoporosis: Insights for the clinician
Glucocorticoids cause significant bone loss, predominantly affecting trabecular bone, with consequent fragility fractures.
- Device-based therapies for resistant hypertension in chronic kidney disease: The continuing quest for a cure
Device-based therapies have shown promise, but many points still need clarification.
- Does a short QT interval increase the risk of cardiac death in healthy people?
No, but it may warrant further investigation to determine if the patient is at risk.
- Clinical presentation and course of COVID-19
Information about the clinical presentation and course of COVID-19 is rapidly evolving.
- Stable coronary artery disease: Intervene or not?
Stable coronary artery disease needs a patient-centered approach, and one size does not fit all.
- Cytokines and the still-baffling clinical biology of COVID-19
The primary culprit is not certain. Is it all immune damage, or is the continued persistence of coronavirus playing a role?
- Mönckeberg medial sclerosis
A man with chronic kidney disease presents with pain and ulceration of the fingers.